Evidence map›Paper›PMID 34404348›Full record

Observational studyBMC infectious diseases2021

Use of monitoring indicators in hospital management of antimicrobials.

Ravena Melo Ribeiro da Silva, Simonize Cunha B de Mendonça, Ingrid Novaes Leão, Quesia Nery Dos Santos, Alessandra Macedo Batista, Matheus Santos Melo, Milena da Motta Xavier, Lucindo José Quintans Júnior, Wellington Barros da Silva, Iza Maria Fraga Lobo

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ravena Melo Ribeiro da SilvaDepartment of Pharmacy, Federal University of Sergipe, São Cristóvão, Se, Brazil. ravena_melo_@hotmail.com.ORCID http://orcid.org/0000-0002-0923-7704
Simonize Cunha B de MendonçaUniversity Hospital, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Ingrid Novaes LeãoGeneral Hospital Prado Valadares, Jequié, Ba, Brazil.
Quesia Nery Dos SantosDepartment of Pharmacy, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Alessandra Macedo BatistaDepartment of Pharmacy, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Matheus Santos MeloDepartment of Nursing, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Milena da Motta XavierUniversity Hospital, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Lucindo José Quintans JúniorDepartment of Physiology, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Wellington Barros da SilvaDepartment of Pharmacy, Federal University of Sergipe, São Cristóvão, Se, Brazil.
Iza Maria Fraga LoboEmergency Hospital of Sergipe, Aracaju, Se, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to the literature, 25% to 50% of antimicrobials prescribed in hospitals are unnecessary or inappropriate, directly impacting antimicrobial resistance. Thus, the present study aimed to evaluate the use of antimicrobials in a university hospital in Northeast Brazil, using days of therapy (DOT) and length of therapy (LOT) indicators in accordance with the latest national and international recommendations for monitoring the use of antimicrobials.

methodsThis is an observational, prospective analytical study conducted in a teaching hospital, with 94 active beds, distributed between the intensive care unit (ICU), the surgical clinic (SUR), the medical clinic (MED), the pneumology/infectology department (PNE/INF) and pediatrics (PED). The duration of the study was from the beginning of January to the end of December 2018.

resultsDuring the study period, a total of 11,634 patient-days were followed up and 50.4% of the patients were found to have received some antimicrobial, with a significant reduction in use of 1% per month throughout the year. Patients were receiving antimicrobial therapy for 376 days in every 1000 days of hospitalization (LOT = 376/1000pd). Overall, the 1st-generation cephalosporins and fluoroquinolones were the most used in respect of the number of prescriptions and the duration of therapy. The calculated global DOT/LOT ratio showed that each patient received an average of 1.5 antimicrobials during the hospital stay. The incidence of antimicrobial resistance, globally, for both methicillin-resistant Staphylococcus aureus (methicillin R), Carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii (Carbapenem R), was 1 per 1000 patient-days.

conclusionsThe results obtained from the analyses revealed that half of the patients admitted to the hospital who took part in the study were exposed to the use of antimicrobials at some point during their stay. Although moderate, it is noteworthy that there was a decline in the use of antimicrobials throughout the year. The indicators used in this study were found to be very effective for gathering data on the use of antimicrobials, and assessing the results of the initiatives taken as part of the Stewardship program.

Indexed as

Anti-Infective AgentsMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsCarbapenemsChildHospitalsHumansProspective StudiesAnti-Bacterial AgentsAnti-Infective AgentsCarbapenemsAnti-infective agentsAntimicrobial stewardshipDrug resistance

Identifiers

PMID34404348
PMCPMC8369325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.